Hearing on "Safeguarding Pharmaceutical Supply Chains in a Global Economy" | Democrats, Energy and Commerce Committee

Hearing on "Safeguarding Pharmaceutical Supply Chains in a Global Economy" | Democrats, Energy and Commerce Committee

In case you missed it

• Janet Woodcock, MD, Director of the FDA Center for Drug Evaluation and Research (CDER), testified before the House Committee on Energy and Commerce, Subcommittee on Health, on Safeguarding Pharmaceutical Supply Chains in a Global Economy. Dr. Woodcock's statement includes information about advanced manufacturing, including medical countermeasure manufacturing, and implications for national security. More about Advanced Manufacturing at FDA (October 30, 2019)